What does this research mean for the field?

Patch test reactivity to Compositae Mix and Sesquiterpene Lactone Mix can persist in patients undergoing anti-IL-4/IL-13 therapy. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Assess whether targeted anti-IL-4 and anti-IL-13 biologic therapy suppresses patch test reactivity to Compositae mix and sesquiterpene lactone mix.

August 30, 2026Contact DermatitisOpen Access

Persistent Patch Test Reactivity to Compositae Mix and Sesquiterpene Lactone Mix During Anti‐ IL ‐4/ IL ‐13 Therapy in Two Cases

View Full Paper

Ask AI

Bookmark

Assess whether targeted anti-IL-4 and anti-IL-13 biologic therapy suppresses patch test reactivity to Compositae mix and sesquiterpene lactone mix.
Evaluated contact allergy via patch testing in two clinical cases undergoing anti-IL-4/IL-13 biologic therapy.
Tested skin sensitivity specifically against Compositae mix and sesquiterpene lactone mix.
Both patients demonstrated persistent positive patch test reactions to Compositae mix and sesquiterpene lactone mix despite active anti-IL-4/IL-13 blockade.
Therapeutic inhibition of IL-4 and IL-13 signaling failed to abolish type IV hypersensitivity responses to these specific plant-derived allergens.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Case series observes persistent patch test reactivity to plant allergens during anti-IL-4/IL-13 treatment, indicating that targeted biologic therapy does not suppress all contact allergies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rubino et al. (2026) studied this question.

synapsesocial.com/papers/6a93f1056c1a8fb52e79db08 https://doi.org/10.1111/cod.70239

View Full Paper

Ask AI

Bookmark

Implication

Case series observes persistent patch test reactivity to plant allergens during anti-IL-4/IL-13 treatment, indicating that targeted biologic therapy does not suppress all contact allergies.

Persistent Patch Test Reactivity to Compositae Mix and Sesquiterpene Lactone Mix During Anti‐ IL ‐4/ IL ‐13 Therapy in Two Cases

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Persistent Patch Test Reactivity to Compositae Mix and Sesquiterpene Lactone Mix During Anti‐ IL ‐4/ IL ‐13 Therapy in Two Cases

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading